A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life
Clinical trial NCT03774875 · COMPLETED
Trial details
- NCT number
- NCT03774875
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-28
- Primary completion
- 2021-02-01
- Enrollment
- 277
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.